Home > News > pSivida Completes Manufacturing Infrastructure for BrachySil(TM)
September 15th, 2005
pSivida Completes Manufacturing Infrastructure for BrachySil(TM)
Abstract:
Global nanotechnology company pSivida Limited today announced its manufacturing partner QSA has completed the construction and validation of a state-of-the-art cleanroom facility, dedicated to the supply of pSivida's lead cancer therapy BrachySil(TM), at QSA's Auriga Medical(TM) facility in Braunschweig, Germany.
Source:
businesswire
Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |